摘要 |
Methods are provided for monitoring treatment of a subject using heparin therapy or a ligand, such as an CD20 or CD52 antibody, that binds to a cellular marker and to which the subject may develop masking reactions or auto-antibodies that inhibit evaluation of treatment. The methods involve adding to a single container a sample containing cells that express the cellular target with (i) a soluble ligand that binds the cellular target, (ii) a soluble ligand that binds the soluble analyte or a competing soluble analyte; and (iii) a capture medium that binds directly to the soluble analyte, indirectly to the soluble analyte, or to the soluble ligand that binds to the soluble analyte. Complexes formed in the container by interaction of these components are substantially simultaneously analyzed and quantitated without physically separating the complexes. Kits for performing the assays are also provided. |
申请人 |
BECKMAN COULTER, INC.;MILLS, RHONDA, A.;QUINTANA, JORGE, A.;MAPLES, JOHN, A.;SCIBELLI, PAUL, M.;HASHIMOTO, WATARU |
发明人 |
MILLS, RHONDA, A.;QUINTANA, JORGE, A.;MAPLES, JOHN, A.;SCIBELLI, PAUL, M.;HASHIMOTO, WATARU |